Abstract
Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
Z Terashita, M Kawamura, M Takatani, S Tsushima, Y Imura and K Nishikawa
Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 748-755;